MedPath

Potassium

Generic Name
Potassium
Drug Type
Small Molecule
Chemical Formula
K
CAS Number
7440-09-7
Unique Ingredient Identifier
RWP5GA015D
Background

Potassium is an essential nutrient, like Calcium and Magnesium. It was identified as a shortfall nutrient by the 2015-2020 Advisory Committee of Dietary Guidelines for Americans. Many conditions and diseases interfere with normal body potassium balance, and underconsumption of potassium is one example. Hypokalemia (low potassium) or hyperkalemia (high potassium) may result, manifesting as various signs and symptoms. Some examples of potassium-related complications include life-threatening arrhythmia, neuromuscular dysfunction, diarrhea, nausea, and vomiting.

Various pharmacological preparations have been formulated to replenish potassium. They are available in an assortment of tablet, injection, and other forms, depending on the setting and condition being treated. Potassium is often a key ingredient for intravenous fluids, given to patients in clinical settings for rehydration, nutrition, and replenishment of electrolytes. Examples of potassium formulations include potassium citrate, potassium chloride, and potassium with dextrose and sodium chloride.

Indication

General uses of potassium

Potassium is indicated to treat a variety of conditions. Firstly, it used to replenish potassium that has been depleted by conditions including but not limited to malabsorption, decreased intake, or excess sodium intake. The causes of potassium deficiency are numerous. The following indications for potassium are not comprehensive, but include the main indications for which this nutrient is used. Various products and preparations contain potassium.

Potassium chloride

Potassium chloride is one of the main preparations of potassium used in a clinical setting. The oral solution is indicated for the prevention and treatment of hypokalemia presenting with or without metabolic alkalosis, in patients who have failed conservative management with potassium-rich foods or diuretic dose titrations. The injection form of potassium chloride is indicated to replenish potassium in patients who are not feasible candidates for oral potassium. Highly concentrated potassium is intended for the treatment of potassium deficiency in fluid restricted individuals who cannot tolerate fluid volumes normally associated with injected potassium solutions that contain lower concentrations.

Finally, the extended-release tablet preparation of potassium chloride is used to treat hypokalemia with or without metabolic alkalosis, to treat digitalis intoxication, and to manage patients with hypokalemic familial periodic paralysis. It is also used in the prevention of hypokalemia in those who are at a high risk of negative clinical outcomes if hypokalemia occurs; patients on digitalis or those with cardiac arrhythmias would be at particular risk of negative outcomes.

Potassium chloride with dextrose and sodium chloride

This liquid preparation is is indicated in a clinical setting as a source of water, calories and electrolytes. Potassium acetate solution is meant as an alternative to potassium chloride, replenishing potassium and added to large volume infusion fluids for intravenous injection.

Potassium citrate

The potassium citrate preparation is used for the management of renal tubular acidosis (RTA) with calcium stones (nephrolithiasis); calcium oxalate stones by any cause, and uric acid nephrolithiasis (with or without calcium stones). This regimen also includes adequate water intake (leading to a urine out put of 2 L/day or more) and sodium restriction.

Associated Conditions
Caloric Intake, Electrolyte and fluid balance conditions, Hydration, Hypokalemia, Potassium

Exploratory Study on the Treatment of Gout With Potassium Citrate Sustained-release Tablets

Phase 4
Recruiting
Conditions
Hyperuricemia or Gout
Nephrolithiasis
Interventions
Drug: uric-acid-lowering drug
Drug: Sodium Bicarbonate Oral Capsule
First Posted Date
2025-05-13
Last Posted Date
2025-05-13
Lead Sponsor
Huashan Hospital
Target Recruit Count
312
Registration Number
NCT06966635
Locations
🇨🇳

Huashan hospital, Fudan university, Shanghai, China

Role of Medication in Making Urine Less Acidic As Part of Kidney Stone Prevention

Phase 1
Not yet recruiting
Conditions
Kidney Calculi
Interventions
First Posted Date
2025-02-11
Last Posted Date
2025-02-11
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
20
Registration Number
NCT06819111

Potassium Nitrate Gel and Diode Laser for Dentinal Hypersensitivity

Not Applicable
Completed
Conditions
Hypersensitivity Dentin
Interventions
Combination Product: Potassium Nitrate Gel and Diode Laser Therapy
First Posted Date
2024-12-24
Last Posted Date
2024-12-24
Lead Sponsor
University of Modena and Reggio Emilia
Target Recruit Count
12
Registration Number
NCT06746558
Locations
🇮🇹

Università degli Studi di Pavia, Department of Orthodontics, Pavia, PV, Italy

High-dose Dual Therapy and Minocycline-cotaining Quadruple Therapy for Helicobacter Pylori Infection

Phase 4
Recruiting
Conditions
Helicobacter Pylori Infection
Interventions
First Posted Date
2024-08-20
Last Posted Date
2024-12-30
Lead Sponsor
Shanghai Jiao Tong University School of Medicine
Target Recruit Count
200
Registration Number
NCT06561698
Locations
🇨🇳

Hebi People's Hospital, Hebi, Henan, China

🇨🇳

Jiaozuo People's Hospital, Jiaozuo, Henan, China

🇨🇳

Luoyang central Hospital, Luoyang, Henan, China

and more 7 locations

Optimization of Minocycline for Helicobacter Pylori Rescue Treatment

Phase 4
Recruiting
Conditions
Helicobacter Pylori Infection
Interventions
Drug: Minocycline,Metronidazole
Drug: Tetracycline,Metronidazole
First Posted Date
2024-08-20
Last Posted Date
2024-12-30
Lead Sponsor
Shanghai Jiao Tong University School of Medicine
Target Recruit Count
476
Registration Number
NCT06561711
Locations
🇨🇳

Peking University Third Hospital, Beijing, Beijing, China

🇨🇳

Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai, China

🇨🇳

Songjiang Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai, China

and more 1 locations

Efficacy and Safety of Tegoprazan and Minocycline Dual Therapy for Helicobacter Pylori Initial Treatment

Phase 4
Not yet recruiting
Conditions
Helicobacter Pylori Infection Chronic Gastrit
Interventions
First Posted Date
2024-07-26
Last Posted Date
2024-07-30
Lead Sponsor
Xijing Hospital of Digestive Diseases
Target Recruit Count
208
Registration Number
NCT06523764

Effect of Sex on Orthostatic Intolerance and Cardiovascular Response During Lunar Descent and Ascent

Not Applicable
Recruiting
Conditions
Healthy
Interventions
First Posted Date
2024-06-21
Last Posted Date
2025-04-01
Lead Sponsor
National Aeronautics and Space Administration (NASA)
Target Recruit Count
38
Registration Number
NCT06467825
Locations
🇺🇸

NASA, Houston, Texas, United States

Sequential Tegafur-gimeracil-oteracil Potassium Capsule (s-1) and Serplulimab Following Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma

Phase 2
Recruiting
Conditions
Locally Advanced Inoperable Esophageal Squamous Cell Carcinoma
Interventions
First Posted Date
2024-05-21
Last Posted Date
2025-05-09
Lead Sponsor
Zhejiang Cancer Hospital
Target Recruit Count
37
Registration Number
NCT06422858
Locations
🇨🇳

Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China

Gender-based Differences in the Outcome of Treatment With Aldosterone Antagonists in Patients With Heart Failure

Completed
Conditions
Heart Failure
Heart Failure With Reduced Ejection Fraction
Heart Failure NYHA Class IV
Heart Failure NYHA Class II
Heart Failure NYHA Class III
Interventions
First Posted Date
2024-01-31
Last Posted Date
2024-02-26
Lead Sponsor
Alexandria University
Target Recruit Count
100
Registration Number
NCT06233695
Locations
🇪🇬

Faculty of Medicine, Alexandria University Hospitals, Alexandria, Egypt

Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Sinusitis

Phase 4
Active, not recruiting
Conditions
Sinus Infection
Acute Sinusitis
Interventions
First Posted Date
2023-10-10
Last Posted Date
2025-01-10
Lead Sponsor
Daniel Merenstein
Target Recruit Count
3720
Registration Number
NCT06076304
Locations
🇺🇸

University of California, Los Angeles, Los Angeles, California, United States

🇺🇸

Georgetown University Medical Center, Washington, District of Columbia, United States

🇺🇸

MedStar Health Research Institute, Hyattsville, Maryland, United States

and more 4 locations
© Copyright 2025. All Rights Reserved by MedPath